Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CONTROL Study of canagliflozin after bariatric surgery
2019-004041-32Phase 2Unknown
- Sponsor
- University of Leicester
- Start
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of canagliflozin in postprandial hypoglycemia (2 arms), sponsored by University of Leicester. Primary endpoint: Nadir glucose during mixed meal tolerance test. Status: unknown.
02
Drugs
canagliflozin
03
Conditions
postprandial hypoglycemia
Beyond the preview
Go deeper on 2019-004041-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-004041-32.